The Efficacy and Safety of First-line Treatment Combined With Immunotherapy for Advanced Hepatocellular Carcinoma: a Single Center, Real-world Study

NCT07078292 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)
Real World Study

Sponsor

Tianjin Medical University Cancer Institute and Hospital